Dyne Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
CGEM
Cullinan Oncology, Inc. |
$11.78 | $1.29 B | -7.16 | 111 | $0 |
CYTK
Cytokinetics, Incorporated |
$49.19 | $6.05 B | -9.78 | 498 | $18.47 M |
DICE
DICE Therapeutics, Inc. |
$47.55 | $2.27 B | -21.91 | 71 | $0 |
DSGN
Design Therapeutics, Inc. |
$6.31 | $217.51 M | -3.7 | 54 | $0 |
ERAS
Erasca, Inc. |
$2.67 | $647.94 M | -2.83 | 126 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$26.56 | $1.65 B | -11.47 | 110 | $0 |
GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 | $0 |
KRTX
Karuna Therapeutics, Inc. |
$329.83 | $12.60 B | -28.09 | 339 | $654,000 |
MLYS
Mineralys Therapeutics, Inc. |
$13.05 | $652.38 M | -6.03 | 51 | $0 |
PLRX
Pliant Therapeutics, Inc. |
$13.18 | $672.63 M | -3.9 | 171 | $0 |
RVMD
Revolution Medicines, Inc. |
$43.84 | $6.66 B | -10.51 | 534 | $0 |
STOK
Stoke Therapeutics, Inc. |
$11.02 | $774.50 M | -6.14 | 110 | $8.78 M |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
